Compare ASIX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASIX | BVS |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 466.9M | 482.9M |
| IPO Year | N/A | 2021 |
| Metric | ASIX | BVS |
|---|---|---|
| Price | $17.77 | $7.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $32.00 | $13.50 |
| AVG Volume (30 Days) | ★ 736.2K | 287.0K |
| Earning Date | 02-20-2026 | 11-04-2025 |
| Dividend Yield | ★ 3.84% | N/A |
| EPS Growth | ★ 35.47 | N/A |
| EPS | ★ 1.92 | 0.15 |
| Revenue | ★ $1,491,348,000.00 | $563,829,000.00 |
| Revenue This Year | $4.71 | N/A |
| Revenue Next Year | $4.59 | $7.11 |
| P/E Ratio | ★ $8.68 | $49.29 |
| Revenue Growth | N/A | ★ 1.58 |
| 52 Week Low | $14.10 | $5.81 |
| 52 Week High | $32.58 | $11.25 |
| Indicator | ASIX | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 61.23 | 54.83 |
| Support Level | $17.10 | $7.14 |
| Resistance Level | $17.69 | $7.65 |
| Average True Range (ATR) | 0.59 | 0.28 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 100.00 | 60.26 |
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.